Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Why Enveric Biosciences (NASDAQ: ENVB) may still be overlooked despite PTSD trial progress Enveric stock dips despite FDA and PTSD progress on EB-003. Find out why investors are cautious and what milestones could restore confidence. byVenkateshNovember 15, 2025